Form 4: Cigna Group Executive Nicole Jones Reports Stock Option Exercises and Sales
SEC Form 4
Nicole Jones, a Cigna Group executive, reported exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 12, 2024, Nicole Jones, EVP, Chief Administrative Officer and General Counsel of Cigna Group, exercised stock options to acquire 15,030 shares of common stock at a price of $149.135 per share.
- Simultaneously, Jones sold 22,030 shares of Cigna Group common stock at a price of $330.96 per share.
- On August 13, 2024, Jones exercised additional stock options to acquire 2,636 shares at $149.135 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on May 10, 2024.
- Following these transactions, Jones directly owns 24,587 shares of Cigna Group common stock.
- Jones also indirectly owns 1,393.7598 shares through participation in The Cigna Group's 401(k) Plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan, with no indication of positive or negative implications for the company.
Positives
- The use of a pre-arranged Rule 10b5-1 trading plan suggests that the transactions were planned and not based on insider information.
Industry Context
Executive stock option exercises and sales are a common occurrence in publicly traded companies and are often governed by pre-arranged trading plans to avoid insider trading concerns.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in the healthcare industry, similar to companies like UnitedHealth Group, Anthem (now Elevance Health), and Humana.
- Rule 10b5-1 trading plans are widely used by corporate insiders across various industries to manage their stock transactions in compliance with securities laws.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the size of the transactions relative to the company's overall market capitalization.
Key Dates
| Date | Description |
|---|---|
| 02/28/2017 | Date of original stock option grant. |
| 02/28/2018 | First vesting date of the stock option grant. |
| 05/10/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 08/12/2024 | Date of stock option exercise and share sale. |
| 08/13/2024 | Date of additional stock option exercise. |
| 08/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.